Continue to content

Satellite 1 - Sanofi | State-of-the-art NK cells therapies in hematological malignancies

Chairs: Xavier Poiré


- Cell biology of NK cells

Sébastien Anguille, Antwerp University Hospital, Belgium

- NK cell therapies
Evren Alici, Huddinge Karolinska Institutet, Stockholm, Sweden

- Strategies to Enhance NK Cell Therapy Efficacy Clinical aspect of NK cell engagers (NKCE)
Eric Vivier, (Aix-Marseille University / Public Hospital of Marseille (AP-HM), France

In short

Information sheet

Presenter
Presenters: Xavier Poiré, Sébastien Anguille, Evren Alici, Eric Vivier

Member login required

This content is part of our learning materials for our members. Login or see our membership information

Login as a member

Access this content and your dashboard by logging in.
Login

Not a member yet?

more than 200 resources for doctors and nurses to epxlore.
See memberships